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Abstract.There have been many controversies on how we should treat patients with  preeclampsia, how and when 
we should deliver the baby. This case report is purposed to evaluate one case of spontaneous parturition which 
ended up with vaginal delivery in one patient with preterm severe preeclampsia. We evaluate the best 
management which result in the best outcome for the patient and her baby. This is the case of Mrs N, 34 years old 
in 33-34 weeks gestational age with severe preeclampsia. When she came the blood pressure was 190/120 
mmHg, protein urine +3. The blood pressure was controlled with nifedipine. The patient was given magnesium 
sulphate, N-acetyl cystein, and vitamin C as antioxidants. We were succeeded in completing two days of lung 
maturation with dexamethasone in order to give the best outcome for the baby. However, at the end, after two 
days of lung maturation, the patient started to enter the active phase of parturition spontaneously without labor of 
induction. We hypothesized that the high level of corticosteroid stimulated by the fetus initiated the process of 
labor. Patient delivered baby boy, 1300 grams, Apgar Score 7/8 that breathed spontaneously in room air. The 
patient’s condition was improving after parturition. Nifedipine, magnesium sulphate was considered the best 
management in pre-eclampsia.  Short course of lung maturation with dexamethasone was also considered to be 
beneficial for the baby. However, the initiation of parturition and the use of antioxidant as well as n-acetyl cystein 
in this patients was under debatable discussion. 
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Introduction 
Preeclampsia is a multisystem disorder, characterized by gestational hypertension and 
proteinuria. It is a common and serious complication in pregnancy. It occurs as much as 
10% of pregnancies and poses a significant risk to both the fetus and the mothers. It can 
be accompanied by maternal symptoms, abnormal maternal laboratory results, or intra-
uterine growth restriction. Various hypotheses as to the origin of preeclampsia have been 
explored but it is difficult to study for several reasons. One limitation is due to the fact that 
preeclampsia clinically present in the second and third trimester of pregnancy but actually 
originate early in pregnancy.  
The pathophysiology of preeclampsia involved the process of implantation, 
endothelial dysfunction, systemic inflammatory response, oxidative stress, angiogenetic 
factors, as well as genetic predisposition. The improper placental implantation contributed 
to surface molecule expression, systemic inflammatory response, endothelial disfunction, as 
well as oxidative stress. The clinical course of severe preeclampsia is characterized by 
progressive deterioration if delivery is not pursued. But in the case of premature patient 
less than 34 weeks of gestational age with severe preeclampsia, delivery would result in 
worse prognosis for the fetus due to lung immaturity. Expectant management to induce 
fetal lung maturity is therefore an option for severe preeclampsia patient less that 34 weeks 
of gestational age. This paper discuss the essential and benefit of expectant management in 
patient with severe preeclampsia and preterm fetus in order to improve the outcome for 
mother and her baby.   
 
Materials and Methods 
This is the case report of Mrs N, 34 years old referred by Fauziah Hospital, Bireun, Aceh 
because of severe preeclampsia and uncontrolled blood pressure. She was in her first 
pregnancy at 33-34 weeks of gestational age after getting married one year ago. There was 
no history of using contraceptives and no history of infertility. She went to antenatal care at 
midwives regularly, once a month and there was no history of hypertension before 
pregnancy and during her antenatal visit. Her last visit was yesterday when her midwife 
found her blood pressure was elevated, 170/110 mmHg and referred her to Fauziah 
General Hospital. Because of there was no intensive care unit and her blood pressure was 
uncontrolled, she was referred to Zainoel Abidin General Hospital. On admission, there was 
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no symptoms of severe headache, epigastric pain, nausea, vomiting, and blurred vision. No 
complaint of vaginal discharge, water broke, vaginal bleeding and contraction. She still felt 
active movement of her baby. Her menstrual period was unremarkable and regular.  
On physical examination, her weight was 50 kg, her height was 160 cm, body mass 
index was 19,5 kg/m2. Her systolic blood pressure was 190 mmHg and diastolic blood 
pressure was 120 mmHg. Her respiratory rate was 20 times per minute and her heart rate 
was 88 times per minute. General examination was normal, auscultation of lung and heart 
was within normal limit. There was edema on her lower extremities. On obstetrics 
examination, the fundal height was 25 cm, head presentation singleton fetus, fetal heart 
beat was 148 beats per minute and regular, there was no contraction, estimated fetal 
weight was 1700 grams. On vaginal examination, the cervix was firm, 3 cm thickness, no 
dilatation, the fetal head was floating from pelvic inlet. Non-stress test cardiotocography 
was reassuring with baseline 140 beats per minute, variability 5-25 beats per minute, 
acceleration was positive, no deceleration, and active fetal movement. On ultrasound 
findings, there was singleton head presentation live fetus, biparietal diameter was 8.13 cm, 
head circumference was 26.7 cm, abdominal circumference was 21.3 cm, ratio of head 
circumference to abdominal circumference was 1.25, femur length was 5.5 cm, ratio of 
systolic to diastolic umbilical artery was 3.00, Amniotic fluid index was 9.5, estimated fetal 
weight was 1500 gram, placenta was in anterior uterine corpus (Figure 1 and 2) 
 
Figure 1. The ultrasound finding showed the elevated ratio of head circumference to 
abdominal circumference 1.25 (>1) which was typical of suspected growth retarded fetus 
 
Figure 2. The umbilical artery Doppler showed a slight increase in ratio of systolic to 
diastolic of 3.00 (≥ 3.00) indicating slight elevated resistance in umbilical artery 
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Laboratory examination revealed hemoglobin 13.8 g/dl, hematocrite 37%, leucocyte 
count 9.300/µL, trombocyte count 112.000/µL, random blood glucose 114 mg/dl, 
ureum/creatinine: 29/0.7, aspartate aminotransferase (AST) 51 U/L, alanine 
aminotransferase (ALT) 22 U/L, and qualitative protein urine +3. 
We diagnosed this patient as gravid 1 33 weeks 6 days of gestational age, suspected 
growth restricted singleton live head presentation fetus, not in labor with severe 
preeclampsia. We managed this patient by giving antihypertension with oral nifedipine 10 
mg per 6 hours and strictly monitor her blood pressure every 30 minutes to keep the target 
systolic blood pressure 140-155 mmHg and diastolic blood pressure between 90-105 
mmHg. We also gave magnesium sulphae as seizures prophylaxis intravenous loading dose 
4 g over 20 minutes, followed by maintenance dose of 1 g/hour. We managed this patient 
expectantly to give steroid for fetal lung maturity enhancement for 48 hours. The steroid 
given was dexamethasone 6 mg per 12 hours for 48 hours. We also delivered antioxidant 
for this patient vitamin C 400 mg every 12 hours intravenous and N-acetylcystein 600 mg 
every 8 hours per oral.  
During the observation the blood pressured was in controlled range, urine output 
and fluid balance was fine. There was no worsening symptoms of severe preeclampsia, no 
deterioration of fetal condition. We succeed in completing 48 hours of lung maturation and 
tried to induce the labor to terminated the pregnancy for this patient. But, after 48 hours, 
the patient started to feel the contraction and the labor was initiated spontaneously without 
induction. In 12 hours the patient delivered 1300 g baby boy, 41 cm, with a 1-minute 
APGAR score of 7 and a 5-minute APGAR score of 8 who breathed spontaneously in room 
air. Ballard Score was equal to 32-34 weeks of gestational age. The baby was admitted to 
neonatal intensive care unit for 18 days. After 18 days treated in neonatal intensive care 
this small for gestational age baby was allowed to go home in fine condition (Figure 3 and 
4) 
 
Figure 3. According to Battaglia and Lubchenco curve, the baby was small for gestational 
age, confirming the condition of growth restricted baby in this patient 
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Figure 4. This 1300 gram small for gestational age baby boy moved vigorously  
and breathed spontaneously in the room air. 
 
 
Result and Discussion 
The risk factors of severe preeclampsia in this patient were advanced maternal age and 
primigravida. The mechanism was related to inappropriate implantation with a disturbed 
utero-placental interaction. This was shown by the occurrence of severe preeclampsia in the 
beginning of third trimester which was characterized by asymmetric intra-uterine growth 
retarded fetus. Abnormal implantation manifested in disturbance of optimal growth in the 
last trimester. According to Sibai et al there was a place for expectant management of 
severe preeclampsia before 34 weeks of gestation in order to give time for lung maturation 
induction. However, the expectant management was controversial in this patient because of 
the occurrence of suspected fetal growth restriction. Many studies showed that patients 
with suspected fetal growth restriction and/or oligohydramnions are not typically considered 
to be candidates for expectant management beyond completion of antenatal corticosteroid 
therapy due to increased risk of adverse outcomes of perinatal death and morbidity. This 
patient was suspected having fetal groth restriction characterized by estimated fetal weight 
below 10 th percentile in 33 weeks 6 days of gestational age (1500 g; <1600 grams), 
abdominal circumference below 5th percentile in 33 weeks 6 days of gestational age (21.3; 
<25.0 cm), elevated ratio of head circumference to abdominal circumference of 1.25 (> 1), 
slightly increased resistance in Doppler study of umbilical artery  (ratio of systolic to 
diastolic umbilical artery =3), and slightly diminished amniotic fluid index (AFI= 9.5 cm; 
<10 cm).  Because the availability of fetal surveillance in our hospital we were challenging 
the risk of delaying delivery in this patient in order to give chance for lung maturation 
induction by corticosteroid.  
This patient with severe preeclampsia and suspected fetal growth restriction should 
be hospitalized to confirm the diagnosis, evaluate maternal and fetal condition, and strict 
monitoring for rapid progression of the disease. Uncontrollable blood pressure, worsening 
symptoms of severe preeclampsia, occurrence of pulmonary edema, abruptio placentae, 
disseminated intravascular coagulation, significant and new-onset renal dysfunction (serum 
creatinine ≥ 1.5 mg/dl), HELLP syndrome, and abnormal fetal surveillance should typically 
be delivered by vaginal or cesarean delivery as appropriate. There was no such worsening 
maternal and fetal condition mentioned above in this patient so we believed that two days 
expectant management to induce lung maturation would give benefit to the fetus. Antenatal 
corticosteroid treatment resulted in less frequent respiratory distress syndrome, neonatal 
death, and intraventricular hemorrhage. In this patient, her baby breathed spontaneously 
in room air and there was no evidence of respiratory distress syndrome. It was still 
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unknown whether it was caused by the induction of fetal lung maturation by 
dexamethasone treatment that we gave or because this growth restricted fetus already 
accelerated his lung maturation by producing adrenal glucocorticoid secretion due to his 
response to stressful environment. However, prolonging pregnancy to induce fetal lung 
maturation for 48 hours was recommended as long as the monitoring maternal and fetal 
condition was available. The decision regarding expectant management for giving induction 
of fetal lung maturation should be individualized in center where continuous maternal 
monitoring and daily fetal surveillance are available.  
Management policy of severe preeclampsia is to start antihypertension to control 
blood pressure and magnesium sulfate intravenously to prevent convulsions. Nifedipine was 
short acting calcium channel blocker proven to be safe in pregnant women without adverse 
effect. It is simply given initially of 10 mg orally every 6 hours and can be increased as 
needed up to 20 mg every 4 hours (40-120 mg/day).  The aim of antihypertensive therapy 
is to keep systolic blood pressure between 140-155 mmHg and diastolic blood pressure 
between 90 and 105 mmHg. If there is recurrent persistent severe hypertension increased 
from the target range despite adequate or maximum dose of antihypertensive therapy, 
delivery should be pursued after maternal stabilization. In this patient, nifedipine given 10 
mg orally every 6 hours was proven to be effective in controlling the blood pressure in the 
target range. The Magpie randomized controlled trial collaborative group recommended the 
use of magnesium sulfate as seizure prophylaxis since it halves the risk of eclampsia and 
proves to be safe to the mother or baby if it is used in short term. In this patient, 
magnesium sulphate was delivered intravenously 4 g initially and maintained at the dose of 
1 g/hour. The magnesium sulphate was given for 24 hours. No deterioration of maternal 
and fetal condition observed in this patient supporting the use o magnesium suphate as the 
safe prophylaxis for eclampsia. 
Small scales studies indicated supplementing vitamin C as antioxidant resulted in 
beneficial effect of biochemical endpoint. Preeclampsia was characterized by oxidative 
stress and systemic inflammatory reaction suggesting the role of antioxidant such as 
vitamin C and N-acetylcystein in preeclampsia. According to Cochraine review, the use of 
antioxidant in preeclampsia remained inconclusive. Some authors suggest the use of 
antioxidant as the prophylaxis of pregnancy which was delivered earlier before conception 
in order to give the better result since the indicators of oxidative stress was found before 
pregnancy.  Some other authors suggest that delivery of antioxidant in established third 
trimester preeclampsia in pregnancy was not associated with adverse maternal and fetal 
effect and worth to try. In this patient we used vitamin C and N-acetylcystein for 
antioxidant. There was no compliant for the use of antioxidant in this patient even though 
several studies reported the complaints of gastrointestinal and abdominal pain from the 
patients treated with vitamin C as antioxidant therapy. 
There were several ways involved in the initiation of parturition. The mechanism 
involved were corticotrophin-releasing hormone (CRH) from maternal secretion, CRH 
production by placenta, CRH production stimulated by the fetus, membrane activation, 
myometrial contraction, progesterone withdrawal, cervical softening, inflammation 
activation and the onset of labor. This patient was in severe preeclampsia under expectant 
management using corticosteroid to induce fetal lung maturation. It was in her 34 weeks of 
gestational age. The initiation of parturition was suspected  because of stimulation of the 
fetal pituitary by CRH increases corticotropin production and, consequently, the synthesis of 
cortisol by the fetal adrenal gland and maturation of the fetal lungs. In turn, the rising 
cortisol concentrations in the fetus further stimulate placental CRH production. The 
maturation of the fetal lungs as a result of increasing cortisol concentrations is associated 
with increased production of surfactant protein A and phospholipids, both of which have 
proinflammatory actions and may stimulate myometrial contractility through increased 
production of prostaglandins by fetal membranes and the myometrium. Feto placental unit 
aminopeptidase was activated and promoted the initiation of parturition. This patient was 
given steroid for lung maturation. It was probably that cortisol synthesized by the fetus 
stimulated feto placental unit which activated CRH production resulting in miometrial 
contraction, inflammation, cervical softening, membrane activation, and initiation of labor 
spontaneously. 
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Conclusion 
The management of preeclampsia comprised of maintaining no progression of worsening 
symptoms for mother and fetus as well as expectant management of severe preeclampsia 
before 34 weeks of gestation to improve perinatal outcome. This case report suggests that 
lung maturation, antihypertensive treatment with nifedipine, magnesium sulphate therapy 
was beneficial in improving the outcome for neonates and mother.   
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